טוען...
Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia
BACKGROUND: Asimadoline, a kappa-opioid agonist, reduces visceral sensitivity in experimental animal models and may decrease satiation and postprandial fullness in healthy individuals. However, its effect on satiation in functional dyspepsia is unclear, and any symptom benefit has not been explored....
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3935285/ https://ncbi.nlm.nih.gov/pubmed/18331462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2008.03676.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|